Esophageal Neoplasms
Showing 1 - 25 of 4,187
Esophageal Tumors, Endoscopic Mucosal Resection, Hyaluronic Acid Trial in São Paulo (Submucous Endoscopic Dissection with
Recruiting
- Esophageal Neoplasms
- +2 more
- Submucous Endoscopic Dissection with hydroxyethylamide
- Submucous Endoscopic Dissection with Hyaluronic acid (TS-905 Blue Eye)
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Oct 16, 2023
Esophageal Cancer, Esophageal Tumors Trial in Boston (Prehabilitation Program)
Not yet recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- Prehabilitation Program
-
Boston, MassachusettsMassachusetts General Hospital
Sep 6, 2023
Esophageal Tumors, Dysphagia Trial in São Paulo (Fully Covered Esophageal Prosthesis (FC-SEMS), Partially Covered Esophageal
Recruiting
- Esophageal Neoplasms
- Dysphagia
- Fully Covered Esophageal Prosthesis (FC-SEMS)
- Partially Covered Esophageal Prosthesis (PC-SEMS)
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Oct 4, 2023
Esophageal Tumors, Esophagus Stenosis Trial in Kaohsiung City (Oral prednisolone (30mg/day) for 28 days)
Recruiting
- Esophageal Neoplasms
- Esophagus Stenosis
- Oral prednisolone (30mg/day) for 28 days
-
Kaohsiung City, TaiwanEDA Hospital
Mar 14, 2023
Postoperative Pulmonary Infection in Esophageal Cancer
Completed
- Esophageal Neoplasms
- Pneumonia
- (no location specified)
Feb 13, 2023
Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)
Not yet recruiting
- Esophageal Neoplasms
- +2 more
- Camrelizumab
- +3 more
- (no location specified)
Nov 20, 2022
Esophageal Cancer, Esophageal Tumors, Gastric Cancer Trial in Lund (evidence-based individualized rehabilitation)
Not yet recruiting
- Esophageal Cancer
- +3 more
- evidence-based individualized rehabilitation
-
Lund, SwedenSkåne University Hospital
Jan 16, 2023
Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)
Not yet recruiting
- Esophageal Carcinoma
- Immune Checkpoint Inhibitors
- (no location specified)
Jul 6, 2023
Esophageal Cancer Trial in Ramat Gan (CPAP)
Recruiting
- Esophageal Cancer
- CPAP
-
Ramat Gan, IsraelSheba Medical Center
Sep 13, 2023
Endoscopic Submucosal Dissection Versus Esophagectomy for Early
Completed
- Esophageal Cancer
- Endoscopic submucosal dissection
- Esophagectomy
-
Shanghai, ChinaChanghai Hospital, Naval Medical University
Sep 27, 2023
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for
Recruiting
- Esophageal Neoplasms
-
Ghent, Oost-Vlaanderen, BelgiumUniversity hospital Ghent
Jan 13, 2023
Microbiome of Esophageal Cancer Patients and Post Esophagectomy
Recruiting
- Esophageal Tumors
-
Haifa, IsraelRambam Health Care Campus
Nov 13, 2023
Patients in Esophageal Cancer Clinical Research
Not yet recruiting
- Esophageal Cancer
- (no location specified)
Apr 14, 2023
Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)
Not yet recruiting
- Neoplasms
- +5 more
- Nivolumab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2023
Follow-up Strategy for Esophageal Cancer Patients
Active, not recruiting
- Esophagus Cancer
- follow-up with different time intervals
-
Guangzhou, Guangdong, ChinaJianhua Fu
Sep 13, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)
Recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- hybrid PET/MRI
-
Milano, ItalyDeaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023
Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)
Not yet recruiting
- Esophagus Cancer
- +9 more
- ActivSight
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center - Dept of Cardiothoracic
Jan 31, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Minimally Residual of Esophageal Cancer 001
Recruiting
- Esophageal Carcinoma
- Minimal Residual Disease
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jul 17, 2023
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Immunotherapy;Envafolimab; Esophageal Cancer Trial (Envafolimab, Abraxane, Cisplatin)
Not yet recruiting
- Immunotherapy;Envafolimab; Esophageal Cancer
- Envafolimab
- +2 more
- (no location specified)
Apr 24, 2023
Dose to Cardiac Substructures on Survival in Esophageal Cancer
Recruiting
- Esophagus Cancer
-
Brest, FranceChu Brest
Aug 16, 2023
Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)
Not yet recruiting
- Esophagus Cancer
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Nov 20, 2023
Esophageal Tumors, Adverse Drug Event Trial in Nanjing (dietary supplement, drug, radiation)
Recruiting
- Esophageal Neoplasms
- Adverse Drug Event
- Nutritional Support Team
- +3 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Mar 23, 2023